Innovation and Research

TAVR - A Minimally Invasive Treatment for Aortic Stenosis

The TriHealth Heart Institute is one of the first hospitals in the United States – and one of four in Ohio – to offer transcatheter aortic valve replacement (TAVR), a minimally invasive treatment option for those who are not candidates for open heart surgery or for whom surgery might have increased risk. Benefits of the treatment include:

  • Long-term survival within adults
  • Proven symptomatic relief and improved quality of life
  • A minimally invasive treatment option for quicker recovery

Learn more about the treatment from Cardiologist Puvi Seshiah MD in the latest TriHealth ON CALL or click here for more information.

Tags Heart , Innovation and Research , TriHealth On Call

Last Updated: October 24, 2017